MAA
AMAG

Managed Account Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

Managed Account Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$9.76M Buy
141,379
+38,948
+38% +$2.45M 0.01% 1109
2015
Q1 		$5.6M Buy
102,431
+82,661
+418% +$3.94M ﹤0.01% 1379
2014
Q4 		$843K Buy
+19,770
New +$714K ﹤0.01% 2096

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Managed Account Advisors's AMAG Position: Q2 2015 in Review

Managed Account Advisors increased its AMAG Pharmaceuticals (AMAG) stake by 38% in Q2 2015, buying an estimated $2.45M and bringing the position to 141,379 shares worth $9.76M. The position accounts for 0.01% of the portfolio, ranked #1109.

Managed Account Advisors first reported a position in AMAG in Q4 2014 and has held it in 3 quarters since. 208 funds tracked by Wall St. Rank hold AMAG as of Q2 2015.

  • Managed Account Advisors held 141,379 shares of AMAG Pharmaceuticals worth $9.76M as of Q2 2015.
  • Managed Account Advisors bought 38,948 AMAG Pharmaceuticals shares in Q2 2015, an estimated $2.45M.
  • AMAG Pharmaceuticals made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1109 holding.
  • Managed Account Advisors first reported a position in AMAG Pharmaceuticals in Q4 2014 and has held it in 3 quarters since.
  • 208 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.